| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |